Hence, our data and results from prior reports (14–16, 19, 28, 45, 46) suggest that testosterone with AR and ERα could promote CRC development, while E2 and P4, alongside ERβ and PGR, may act as tumour suppressors. The gene discussed is PGR; the disease is neoplasm.